Abstract:Abstract Background Wilms tumor is the most common pediatric renal cancer. However, genetic bases behind Wilms tumor remain largely unknown. H19 is a critical maternally imprinted gene. Previous studies indicated that single nucleotide polymorphisms (SNPs) in the H19 can modify the risk of several human malignancies. Epigenetic errors at the H19 locus lead to biallelic silencing in Wilms tumors. Genetic variations in the H19 may be related to Wilms tumor susceptibility. Methods We conducted a four‐center study to investigate whether H19 SNP was a predisposing factor to Wilms tumor. Three polymorphisms in the H19 (rs2839698 G > A, rs3024270 C > G, rs217727 G > A) were genotyped in 355 cases and 1070 cancer‐free controls, using Taqman method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. Results We found that all of these three polymorphisms were significantly associated with Wilms tumor risk alterations. The rs2839698 G > A polymorphism (AG vs. GG: adjusted OR = 0.74, 95% CI = 0.57–0.96, p = 0.024; AA vs. GG: adjusted OR = 1.52, 95% CI = 1.05–2.22, p = 0.027), the rs3024270 C > G polymorphism (CG vs. CC: adjusted OR = 0.61, 95% CI = 0.46–0.81, p = 0.0007; and the rs217727 polymorphism (AG vs. GG: adjusted OR = 0.76, 95% CI = 0.58–0.99, p = 0.035). The Carriers of 1, 2, and 1–2 risk genotypes were inclined to develop Wilms tumor compared with those without risk genotype (adjusted OR = 1.36, 95% CI = 1.02–1.80, p = 0.037; adjusted OR = 1.84, 95% CI = 1.27–2.67, p = 0.001; adjusted OR = 1.50, 95% CI = 1.17–1.92, p = 0.002, respectively). The stratified analysis further revealed that rs2839698 AA, rs217727 AA, and 1–2 risk genotypes could strongly increase Wilms tumor risk among children above 18 months of age, males, and with clinical stage I+II disease. Conclusion Our findings indicate that genetic variations in the H19 may confer Wilms tumor risk.

METTL1 Gene Polymorphisms and Wilms Tumor Susceptibility in Chinese Children: A Five-Center Case-Control Study.

METTL14 Gene Polymorphisms Decrease Wilms Tumor Susceptibility in Chinese Children

METTL3 Polymorphisms and Wilms Tumor Susceptibility in Chinese Children: A Five-Center Case-Control Study.

Associations Between LMO1 Gene Polymorphisms and Wilms' Tumor Susceptibility

H19 Gene Polymorphisms and Wilms Tumor Risk in Chinese Children: a Four-Center Case-Control Study.

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

TRMT6 Gene Rs236110 C > A Polymorphism Increases the Risk of Wilms Tumor.

<i>ALKBH5</i> gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study

Association of KRAS and NRAS Gene Polymorphisms with Wilms Tumor Risk: a Four-Center Case-Control Study

YTHDF3 gene polymorphisms increase Wilms tumor risk in Chinese girls

WT1 Mutation As a Cause of 46 XY DSD and Wilm’s Tumour: a Case Report and Literature Review

Role of FTO Gene Polymorphisms in Wilms Tumor Predisposition: A Five‐center Case–control Study

The contribution of <i>YTHDF2</i> gene rs3738067 A>G to the Wilms tumor susceptibility

Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population.

Association of RNA m7G Modification Gene Polymorphisms with Pediatric Glioma Risk

The Contribution of WTAP Gene Variants to Wilms Tumor Susceptibility.

Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population

Role of <i>FTO</i> gene polymorphisms in Wilms tumor predisposition: A five‐center case–control study

Association Between <em>tp53</em> Gene Arg72Pro Polymorphism and Wilms&rsquo; Tumor Risk in a Chinese Population

WDR4 gene polymorphisms increase hepatoblastoma susceptibility in girls

Genetic variations in NER pathway gene polymorphisms and Wilms tumor risk: A six‐center case–control study in East China